Growth Metrics

Mannkind (MNKD) Common Equity (2010 - 2026)

Mannkind (MNKD) reported Common Equity of -$59.2 million for Q1 2026, down 0.98% year-over-year from -$59.8 million in Q1 2025, and down 16.02% on a QoQ basis from -$51.0 million in Q4 2025.

Mannkind (MNKD) has 17 years of Common Equity data on file, last reported at -$59.2 million in Q1 2026.

  • Quarterly Common Equity fell 0.98% year-over-year to -$59.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$59.2 million (down 0.98% YoY) and the FY2025 annual result came in at -$51.0 million, up 35.26% from the prior year.
  • Common Equity slipped to -$59.2 million in Q1 2026 per MNKD's latest filing, from -$51.0 million in the prior quarter.
  • Across five years, Common Equity topped out at -$44.6 million in Q3 2025 and bottomed at -$260.5 million in Q2 2023.
  • The 5-year median for Common Equity is -$230.0 million (2024), against an average of -$176.1 million.
  • The widest annual swing landed in 2022, when Common Equity tumbled 34.6%; it then soared 78.78% in 2025.
  • Tracing MNKD's Common Equity over 5 years: stood at -$250.5 million in 2022, then grew by 1.74% to -$246.2 million in 2023, then jumped by 67.98% to -$78.8 million in 2024, then soared by 35.26% to -$51.0 million in 2025, then decreased by 16.02% to -$59.2 million in 2026.
  • Per Business Quant, the three latest MNKD Common Equity figures stand at -$59.2 million (Q1 2026), -$51.0 million (Q4 2025), and -$44.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -1.42 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 35.63 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.00 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 13.21 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -59.20 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -59.20 Mn
Dec 31, 2025 -51.02 Mn
Sep 30, 2025 -44.55 Mn
Jun 30, 2025 -55.04 Mn
Mar 31, 2025 -58.62 Mn
Dec 31, 2024 -78.82 Mn
Sep 30, 2024 -209.93 Mn
Jun 30, 2024 -225.78 Mn
Mar 31, 2024 -229.97 Mn
Dec 31, 2023 -246.17 Mn
Sep 30, 2023 -251.78 Mn
Jun 30, 2023 -260.49 Mn
Mar 31, 2023 -255.40 Mn
Dec 31, 2022 -250.54 Mn
Sep 30, 2022 -237.68 Mn
Jun 30, 2022 -247.06 Mn
Mar 31, 2022 -232.06 Mn
Dec 31, 2021 -209.35 Mn
Sep 30, 2021 -184.69 Mn
Jun 30, 2021 -183.55 Mn
Mar 31, 2021 -173.62 Mn
Dec 31, 2020 -180.42 Mn
Sep 30, 2020 -186.42 Mn
Jun 30, 2020 -179.71 Mn
Mar 31, 2020 -198.05 Mn
Dec 31, 2019 -190.53 Mn
Sep 30, 2019 -184.71 Mn
Jun 30, 2019 -196.00 Mn
Mar 31, 2019 -188.00 Mn
Dec 31, 2018 -175.08 Mn
Sep 30, 2018 -205.44 Mn
Jun 30, 2018 -206.62 Mn
Mar 31, 2018 -223.21 Mn
Dec 31, 2017 -214.73 Mn
Sep 30, 2017 -251.02 Mn
Jun 30, 2017 -221.24 Mn
Mar 31, 2017 -198.73 Mn
Dec 31, 2016 -183.59 Mn
Sep 30, 2016 -238.69 Mn
Jun 30, 2016 -366.58 Mn
Mar 31, 2016 -373.46 Mn
Dec 31, 2015 -350.33 Mn
Sep 30, 2015 -124.57 Mn
Jun 30, 2015 -115.48 Mn
Mar 31, 2015 -97.03 Mn
Dec 31, 2014 -73.77 Mn
Sep 30, 2014 -40.68 Mn
Jun 30, 2014 -46.38 Mn
Mar 31, 2014 17.54 Mn
Dec 31, 2013 -30.71 Mn
Sep 30, 2013 -167.72 Mn
Jun 30, 2013 -152.36 Mn
Mar 31, 2013 -146.81 Mn
Dec 31, 2012 -110.68 Mn
Sep 30, 2012 -276.25 Mn
Jun 30, 2012 -244.38 Mn
Mar 31, 2012 -277.39 Mn
Dec 31, 2011 -313.65 Mn
Sep 30, 2011 -280.81 Mn
Jun 30, 2011 -245.38 Mn
Dec 31, 2010 -185.53 Mn